← Back to Search

E-cigarettes for Tobacco Use

N/A
Waitlist Available
Research Sponsored by University of Maryland, Baltimore
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 8 weeks
Awards & highlights

Summary

"This trial aims to see if adults over 50 who smoke tobacco and are being treated for opioid use disorder will switch to using e-cigarettes instead of continuing to smoke. The study wants to know if e

Who is the study for?
This trial is for adults aged 50 and older who smoke tobacco and are being treated for opioid use disorder. They should not have any current plans or efforts to quit smoking. The study excludes individuals who do not meet these specific criteria.
What is being tested?
The study tests if providing e-cigarettes can help older adults switch from smoking tobacco to using e-cigarettes, as a harm-reduction tool. It compares the effectiveness of e-cigarettes with standard advice on quitting smoking over several weeks through follow-up visits.
What are the potential side effects?
While the description does not list specific side effects, common concerns with e-cigarette use include throat irritation, coughing, dry mouth, and dependence on nicotine.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Intention to quit smoking in next month
Reduction in cigarettes smoked per day (% change)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: E-cigarette switchingExperimental Treatment1 Intervention
NJOY Ace e-cigarette (menthol or tobacco flavor, depending on patient preference) to be used ad libitum.
Group II: Standard brief advice to address tobacco useActive Control1 Intervention
Patients will be exposed to a brief smoking cessation intervention (BI) based on long-standing tobacco treatment guidelines (Fiore, 2008) and recommendations in the newly revised 4th edition of the ASAM. If a patient reports wanting to stop smoking, they will be instructed to reach out to their medical provider at the treatment clinic. They will be given multiple state and federal resources for quitting smoking. If the patient does not want to quit smoking during the brief intervention, we will check with them during the next session about their interest. The brief smoking intervention will be delivered at each session to check on individuals who are attempting to quit and to possibly motivate those who aren't quitting to initiate a quit attempt.

Find a Location

Who is running the clinical trial?

University of Maryland, BaltimoreLead Sponsor
705 Previous Clinical Trials
378,420 Total Patients Enrolled
~27 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top